Published in Women's Health Weekly, May 15th, 2006
"Biopsy-proven benign breast disease (BBD) is a risk factor for developing breast carcinoma; however, to the authors' knowledge, little is known regarding factors related to progression to carcinoma. A cohort study was conducted to examine the role of cyclooxygenase (COX) polymorphisms and nonsteroidal anti-inflammatory drugs (NSAIDs) in the progression of BBD to breast carcinoma," scientists at Johns Hopkins University reported.
L. Gallicchio and colleagues stated, "Among participants in an ongoing cohort study, 1467 women under-went a breast biopsy for BBD. Of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly